BioNTech

BioNTech is a global immunotherapy brand that aims to improve the health of people worldwide. Founded by scientists and physicians, BioNTech combines fundamental research with operational excellence to translate science into survival. They are committed to developing immunotherapies that harness the power of the immune system to address serious diseases, including cancer and infectious diseases.

BioNTech's portfolio includes a wide range of innovative drug classes and platform technologies. Their mRNA-based therapies deliver genetic information to cells for therapeutic effect, while engineered cell therapies modify a patient's T cells to target cancer-specific antigens. They also develop protein-based therapeutics, such as mono- and bispecific antibodies, antibody-drug conjugates, and synthetic lysins.

Additionally, BioNTech utilizes small molecule immunomodulators to enhance the activity of other drug classes. Through ongoing clinical trials and an extensive pipeline, BioNTech is actively working to achieve medical breakthroughs in oncology and infectious diseases. Join their team of visionaries, scientists, and business professionals to be part of their mission to translate science into survival and improve global health